This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

These are dependent on the particular clinical subgroup of polyarteritis that occurs. Generally, it is found in middle-aged men.

Initially features are non-specific:

  • fever, malaise, weight-loss, arthralgia, myalgia

Later features may include:

  • ear nose and throat - secretory otitis media, sensorineural deafness, epistaxis, nasal obstruction, ulceration of the hard or soft palate.
  • lung - lower respiratory tract involvement in 45-65% of patients; common symptoms dyspnoea, cough, haemoptysis, pleuritic chest pain.
  • joints - affected in about 60%; migratory polyarthralgia is a common symptom in prodrome.
  • muscle - myalgia, weakness - muscle in involvement in 30-80% of patients.
  • eye - red, painful (due to episcleritis) - eye involvement in 40-80% of cases.
  • nervous system:
    • PNS - affected in 50-70% of cases; peripheral neuropathy, mononeuritis multiplex.
    • CNS - occurs in 25%
  • GU tract:
    • kidney involvment in 65-80%; poor prognosis.
  • skin - lesions found in 20-50%; specific lesions eg skin necrosis, subcutaneous nodules, livedo reticularis. Non-specific manifestations such as macular erythema, erythema multiforme and erythema nodosum also may occur.
  • CVS - MI, heart failure, arrhythmias.
  • GI tract - 25-50%; gastrointestinal ischaemia, hepatomegaly in 40%.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.